(Total Views: 573)
Posted On: 10/28/2019 10:52:30 PM
Post# of 155267
Dr. Pourhassan
10/28/2019 Proactive Investor Video
...2:19 “I told everybody we will have a licensing…potential licensing out of Leronlimab for sales in the United States. 90 million dollars milestone payments, uh, 50% royalty, cost of goods plus 10 percent and so forth, and 50 million dollars to launch the product will be paid by that company. So, we have got that all going forward in a great way and we are in the vicinity of very close to announcing some major thing in that regard. So, announcements that are going to come out in my opinion are very strong.”
NP has not wavered from these combo HIV licensing deal highlights since the Sept. 12th shareholders meeting. Bold statement. I believe the ball is in Cytodyn's court and they had a timeline to sign a binding agreement by...why else would he so confidently repeat the details of the ongoing negotiations? Busy shopping around for the past 5-6 weeks, default, a pretty decent deal in hand.
My take: hang in there longs, you will be rewarded.
10/28/2019 Proactive Investor Video
...2:19 “I told everybody we will have a licensing…potential licensing out of Leronlimab for sales in the United States. 90 million dollars milestone payments, uh, 50% royalty, cost of goods plus 10 percent and so forth, and 50 million dollars to launch the product will be paid by that company. So, we have got that all going forward in a great way and we are in the vicinity of very close to announcing some major thing in that regard. So, announcements that are going to come out in my opinion are very strong.”
NP has not wavered from these combo HIV licensing deal highlights since the Sept. 12th shareholders meeting. Bold statement. I believe the ball is in Cytodyn's court and they had a timeline to sign a binding agreement by...why else would he so confidently repeat the details of the ongoing negotiations? Busy shopping around for the past 5-6 weeks, default, a pretty decent deal in hand.
My take: hang in there longs, you will be rewarded.
(1)
(0)
